The Molecular Biology Society of Japan

4066 results (1631 - 1640)

[1P-0663] Molecular mechanisms of cancer drug resistance to nicotinamide phosphoribosyltransferase inhibitor

〇Yoko Ogino1, Akira Sato1,2, Kiyotaka Katsuragi1, Yuri Shibasaki1, Yusuke Takai1, Atsushi Yoshimori3, Takahiro Oyama4, Hideaki Abe4, Sei-ichi Tanuma1,2 (1.Dept. of Biochem., Fac. of Pharm. Sci., Tokyo Univ. of Sci., 2.Genome & Drug Res. Ctr., Tokyo Univ. of Sci., 3.Inst. for Theoretical Med., Inc., 4.Hinoki Shinyaku Co., Ltd)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[1P-0667] Exploration of anticancer agents against synovial sarcoma

〇Hiroyuki Yamasaki1,2, Masatoshi Kawai1,3, Kazutaka Kikuta3, Koichi Matsuda2, Tsutomu Ohta1 (1.Dept. of Innov. Seeds Eval., Natl. Cancer Ctr. Res. Inst., 2.Dept. of Compt. Biol. and Med. Sci., Grad. Sch. of Frontier Sci., Univ. of Tokyo, 3.Sch. of Med., Keio Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[1P-0668] Screening of novel inhibitors targeting poly(ADP-ribose) glycohydrolase

〇Ryosuke Suzuki1, Takahiro Oyama3, Yuki Yahagi1, Hideaki Abe3, Atsushi Yoshimori4, Akira Sato1,2, Sei-ichi Tanuma1,2 (1.Dept. of Biochem., Fac of Pharm. Sci., Tokyo Univ. of Sci., 2.Genome & Drug Res. Ctr., Tokyo Univ. of Sci., 3.Hinoki Shinyaku Co., 4.Institute for Theoretical Medicine, Inc.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[1P-0669] Screening for lead compounds targeting T cell acute lymphoblastic leukemia

〇Kazuya Miyashita1,2, Noritaka Kagaya3, Miho Izumikawa3, Kyoko Watakabe-Inamoto4, Yuho Najima4, Noriko Doki4, Takeshi Kobayashi4, Kazuhiko Kakihana4, Susumu Goyama2, Toshio Kitamura2, Kazuteru Ohashi4, Kazuo Shin-ya3, Takahiko Hara1,5 (1.Stem Cell Project, Tokyo Metropol. Inst. of Med. Sci., 2.Div. of Cellular Therapy, The Inst. of Med. Sci., The Univ. of Tokyo, 3.National Inst. of Advanced Industrial Sci. and Tech., 4.Hematol. Div., Tokyo Metropol. Cancer and Infectious diseases Center, Komagome Hosp., 5.Grad. Sch. of Med. and Dent. Sci., Tokyo Med. and Dent. Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[1P-0670] Development of a novel NF-κB inhibitor

〇Kohki Kido1, Erika Manabe1, Atsushi Uematsu1, Hiroyuki Takeda1, Hirotaka Takahashi1, Tatsuya Sawasaki1 (1.PROS, Ehime Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[1P-0671] Studies on the creation of novel antitumor drugs targeting the key enzyme of NADbiosynthesis , nicotinamide phosphoribosyltransferase

〇Kiyotaka Katsuragi1, Akira Sato1,2, Yoko Ogino1, Yuri Shibasaki1, Yusuke Takai1, Atsushi Yoshimori3, Takahiro Oyama4, Hideaki Abe4, Sei-ichi Tanuma1,2 (1.Dept. of Biochem., Fac. of Pharm. Sci., Tokyo Univ. of Sci., 2.Genome & Drug Res. Ctr., Tokyo Univ. of Sci., 3.Inst. for Theoretical Med., Inc., 4.Hinoki Shinyaku Co., Ltd)

The 39th Annual Meeting of the Molecular Biology Society of Japan

4066 results (1631 - 1640)